Facial Injectables Market Report

Facial Injectables Market Analysis By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application (Aesthetics, Therapeutics), By Region, And Segment Forecasts, 2014 - 2025

Published: May 2017  |  80 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-849-7

Industry Insights

The global facial injectables market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of 11.5% during the forecast period. Increasing aesthetic awareness amongst consumers and growing geriatric population worldwide are anticipated to drive the market growth. Furthermore, increasing shift from invasive to minimally invasive procedures and advancements in facial rejuvenation are expected to support market growth over the forecast period.

Both young and old individuals are becoming increasingly conscious about their physical appearances and are aware of beauty care products and procedures across the world. Hence, consumers are purchasing facial injectables to prevent and delay the formation of glabellar lines and wrinkles. American and Asian consumers are known to be more conscious about their aesthetic appeal, which is expected to significantly contribute to the regional market growth. Consumers are seeking advice and recommendations from experts such as health & beauty specialists to gain knowledge about these products, in order to tackle the commonly encountered adverse effects. Consumers, these days, are well informed about cosmetic products due to awareness created by traditional media channels and social media, which influences the purchasing decisions of consumers positively. Personalized products are gaining traction across the globe due to increasing demand products that are unique and can enhance their personality.

U.S. facial injectables market, by product, 2014 - 2025 (USD Billion)

U.S. facial injectables market

In addition, growing importance of medical aesthetics coupled with increasing spending on aesthetic procedures is expected to assist the market growth. For instance, according to statistics reported by the American Society for Aesthetic Plastic Surgery (ASAPS), nearly USD 12.0 billion was spent by Americans on surgical and nonsurgical aesthetic procedures in 2014, which increased to over USD 13.5 billion in 2015, to more than USD 15.0 billion in 2016. Thus, increasing beauty consciousness amongst consumers coupled with increasing spending over aesthetic procedures is anticipated to propel market growth over the forecast period.

Furthermore, increasing shift from invasive to minimally invasive procedures are expected to spur market growth over the forecast period. The international survey on cosmetics conducted by the International Society of Aesthetic Plastic Surgery (ISAPS) reported that surgical procedures performed in 2014 decreased to 47.7% (9,645,395 surgeries out of 20,236,901 total procedures performed) from 49.4% (11,599,336 surgeries out of 23,474,273 total procedures performed) in 2013 across the world. In addition, worldwide volume of minimally invasive surgeries performed were increased to 52.3% (10,591,506 surgeries out of 20,236,901 total procedures performed) in 2014 from 50.6% (11,874,937 surgeries out of 23,474,273 total procedures performed) in 2013. In addition, minimally invasive surgeries offer advantages that include smaller incisions, shorter hospital stays, rapid wound healing, less pain & surgical wounds, and reduced risk of complications as compared to invasive surgeries. These are expected to fuel the demand for facial injectables during the forecast period.

As per data published by the CIA World Fact Book, about 41.0% of the total German population was aged between 25 to 54 years and around 14.0% of the population was aged between 55 to 65 years in 2016. Similarly, approximately 48.0% of the total population of China was aged between 25 to 54 years in 2016. The elderly population is prone to skin diseases, as with age, the skin wrinkles & loses elasticity. Thus, they form the key target population for aesthetic surgeries and are expected to push the demand for injectables across the world.

On the contrary, adverse effects associated with injectables, such as allergic reactions, nausea, rash, neck & back pain coupled with legal & regulatory issues and safety concerns of botulinum toxin type A (pose high risk to patient safety) are anticipated to restrict the market growth.

Product Insights

The products analyzed in this study are collagen, hyaluronic acid, botulinum toxin type A, calcium hydroxylapatite, and polymer fillers. The hyaluronic acid segment dominated the industry in 2016 and is expected to witness lucrative growth over the forecast period. Increasing use of hyaluronic acid as a dermal filler or in cosmetic preparations is expected to support the market growth. Hyaluronic acid has become an integral part of cosmetics owing to its strong water retention properties. Cosmetic-grade hyaluronic acid has lower molecular weight which firther facilitates deep penetration of the product in the epidermis, helps retain water in the cells, releases antioxidants, and delays the aging process.

The botulinum toxin type A segment is expected to register comparatively higher growth during the forecast period. This is due to the rising application in cosmetics (aesthetics) and is also involved in improving the facial appearance and reduces signs of aging. This product is used for the treatment of frown lines, crow’s feet lines, and glabellar lines. Moreover, botulinum toxin type A finds therapeutic applications in treating benign essential blepharospasm, strabismus or crossed eyes, Meige's syndrome, Oromandibular Dystonia (OMD), Hemifacial Spasms (HFS), and focal hyperhidrosis.

Polymer fillers are further segmented into polymethylmethacrylate beads and poly-L-lactic acid. The polymer fillers segment is expected to register double digit CAGR during the forecast period as it offers advantages of prolonged longevity and reduced adverse effects as compared with other products. They are also used to replace depleted facial volume and enhance facial appearance, correction of shallow to deep nasolabial fold contour deficiencies & other wrinkles, and acne scars.

Collagen injectables are intended for the treatment of wrinkles, laugh lines, creases, lip border restoration, crow's feet, facial rejuvenation and volume loss, face contouring, and acne scars. The collagen segment is anticipated to exhibit favorable market growth over the forecast period due to the increasing use of collagen in facial injectables to correct facial skin imperfections. Some of the commercially available collagen injectables are CosmoDerm and CosmoPlast (ALLERGAN), Bellafill (Suneva Medical, Inc.), and Ellansé (Sinclair Pharma).

Application Insights

The application segment is categorized into aesthetics and therapeutics. The aesthetics segment is expected to dominate the market during the forecast period owing to increasing use of facial injectables for aesthetics procedures such as treatment of parentheses lines, wrinkles on face, lip lines, lip augmentation, lip border restoration, perioral lines, crow’s feet lines, frown lines, glabellar lines, filling furrows (deep wrinkles), periorbital wrinkles, superficial lines, acne scars, tear troughs, marionette lines, lipoatrophy of face, nasolabial folds, chin dimpling, and mouth wrinkles.

Moreover, other aesthetic applications include facial surgeries including plastic surgery and facelift surgery that are used to repair, restore, reconstruct or alter skin, and also reduces facial wrinkles. Facial injectables such as botulinum toxin type A and calcium hydroxylapatite are majorly used during these procedures.

On the other hand, the therapeutic segment is expected to register double-digit CAGR over the forecast period owing to rising applications of facial injectable in blepharospasm, strabismus or crossed eyes, Meige's syndrome, Oromandibular Dystonia (OMD), Hemifacial Spasms (HFS) and focal hyperhidrosis.

Global facial injectables market, by application, 2016 (%)

Global facial injectables market

Regional Insights

North America held over 40.0% share of the facial injectables market in 2016, owing to increased spending on aesthetic procedures. In addition, presence of a large geriatric population base in the U.S. and Canada is likely to fuel the demand for injectables during the forecast period. As per estimates provided by the United States Census Bureau in the year 2014, the geriatric population in the U.S. is projected to reach 83.7 million by 2050 as compared to the population of 43.1 million in 2012. In addition, the Population Reference Bureau report of 2016, projected that aging population in the region is anticipated to increase to 98.0 million by 2060 from 46.0 million in 2016.

Europe is also expected to hold substantial market share over the forecast period owing to increasing consumer disposable income coupled with the presence of highly advanced healthcare infrastructure and manufacturers. This is expected to assist the market growth over the forecast period. Local presence of major players such as ALLERGAN, Ipsen, Sinclair Pharma, and Galderma S.A. are expected to assist the growth of this vertical.

Several emerging Asian economies that have promising economic & demographic landscape coupled with rising aesthetic consciousness amongst consumers in the Asian countries such as India, China, Japan, Australia, and others are expected to propel growth of the market at a comparatively higher CAGR over the forecast period. In addition, increasing adoption of combination treatments and rising number of medical tourists visiting Brazil are expected to support the growth of the Latin American industry during the forecast period.

Several companies are seeking to enter the facial injectable market in China due to the presence of ample opportunities. The presence of key market players such as Bloomage BioTechnology Corporation Limited is also helping in market growth of this country. Moreover, increasing medical and cosmetic tourism coupled with low procedure costs in South Korea is also contributing to the regional revenue growth.

Competitive Outlook

Some of the major players include ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma S.A. These players focus on growth strategies such as new product launches, partnerships, merger & acquisition, and regional expansion.

For instance, in January 2017, ALLERGAN launched Juvéderm Volite, a hyaluronic acid injectable gel that is used to smoothen face lines, neck, décolletage, and hands in adults.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, UK, Germany, Japan, China, India, Brazil, Mexico, & South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope(equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the facial injectables market on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Collagen

    • Hyaluronic Acid (HA)

    • Botulinum Toxin Type A

    • Calcium Hydroxylapatite (CaHA)

    • Polymer Fillers

      • Polymethylmethacrylate Beads (PMMA Microspheres)

      • Poly-L-lactic acid (PLLA)

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Aesthetics

    • Therapeutics

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA